NutriBand (NTRB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.22, -0.80% vs the prior close of $6.27.
- Volume 27.92K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NTRB dips 0.8% to $6.22, 3 down days in a row. Closed at $6.22, -0.80% vs the prior close of $6.27. Day range $6.00–$6.52, opened at $6.34.
NTRB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NTRB dips 0.8% to $6.22, 3 down days in a row
- Closed at $6.22, -0.80% vs the prior close of $6.27. Day range $6.00–$6.52, opened at $6.34.
- Volume was 27.92K shares, 0.3x its 50-day average of 81.11K — lighter than usual.
- Price is +7.2% vs its 50-day average ($5.80) and +45.2% vs its 200-day average ($4.28).
- 52-week range $2.80–$9.19; today's close sits at 54% of that range, 32.3% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — NTRB dips 0.8% to $6.27
- Closed at $6.27, -0.79% vs the prior close of $6.32. Day range $6.25–$6.80, opened at $6.30.
- Volume was 70.20K shares, 0.9x its 50-day average of 79.98K.
- Price is +9.3% vs its 50-day average ($5.73) and +46.7% vs its 200-day average ($4.27).
- 52-week range $2.80–$9.19; today's close sits at 54% of that range, 31.7% below the 52-week high.
Oct 14, 2026 — NTRB slides 3.1% to $6.32
- Closed at $6.32, -3.07% vs the prior close of $6.52. Day range $6.30–$6.64, opened at $6.50.
- Volume was 51.70K shares, 0.7x its 50-day average of 79.09K.
- Price is +11.5% vs its 50-day average ($5.67) and +48.0% vs its 200-day average ($4.27).
- 52-week range $2.80–$9.19; today's close sits at 55% of that range, 31.2% below the 52-week high.
Oct 13, 2026 — NTRB jumps 11.5% to $6.52
- Closed at $6.52, +11.45% vs the prior close of $5.85. Day range $5.89–$6.80, opened at $5.89.
- Volume was 69.00K shares, 0.9x its 50-day average of 77.82K.
- Price is +16.5% vs its 50-day average ($5.60) and +52.9% vs its 200-day average ($4.26).
- 52-week range $2.80–$9.19; today's close sits at 58% of that range, 29.0% below the 52-week high.
Oct 12, 2026 — NTRB slides 12.0% to $5.85, a 1-month low
- Closed at $5.85, -12.03% vs the prior close of $6.65. Day range $5.85–$6.57, opened at $6.57.
- Volume was 15.60K shares, 0.2x its 50-day average of 77.69K — lighter than usual.
- Price is +5.9% vs its 50-day average ($5.52) and +37.5% vs its 200-day average ($4.25).
- 52-week range $2.80–$9.19; today's close sits at 48% of that range, 36.3% below the 52-week high.
Oct 9, 2026 — NTRB jumps 9.9% to $6.65
- Closed at $6.65, +9.92% vs the prior close of $6.05. Day range $5.70–$6.82, opened at $6.00.
- Volume was 45.10K shares, 0.6x its 50-day average of 76.87K — lighter than usual.
- Price is +21.7% vs its 50-day average ($5.46) and +56.5% vs its 200-day average ($4.25).
- 52-week range $2.80–$9.19; today's close sits at 60% of that range, 27.6% below the 52-week high.
Oct 8, 2026 — NTRB slides 10.4% to $6.05
- Closed at $6.05, -10.44% vs the prior close of $6.76. Day range $6.03–$6.75, opened at $6.75.
- Volume was 35.70K shares, 0.5x its 50-day average of 76.25K — lighter than usual.
- Price is +12.3% vs its 50-day average ($5.39) and +42.8% vs its 200-day average ($4.24).
- 52-week range $2.80–$9.19; today's close sits at 51% of that range, 34.1% below the 52-week high.
Oct 7, 2026 — NTRB rises 1.1% to $6.76
- Closed at $6.76, +1.12% vs the prior close of $6.68. Day range $6.58–$7.10, opened at $6.58.
- Volume was 10.20K shares, 0.1x its 50-day average of 76.08K — lighter than usual.
- Price is +26.9% vs its 50-day average ($5.33) and +59.7% vs its 200-day average ($4.23).
- 52-week range $2.80–$9.19; today's close sits at 62% of that range, 26.5% below the 52-week high.
Oct 6, 2026 — NTRB slides 10.6% to $6.68
- Closed at $6.68, -10.58% vs the prior close of $7.47. Day range $6.55–$7.44, opened at $7.44.
- Volume was 87.00K shares, 1.2x its 50-day average of 74.50K.
- Price is +27.3% vs its 50-day average ($5.25) and +58.4% vs its 200-day average ($4.22).
- 52-week range $2.80–$9.19; today's close sits at 61% of that range, 27.3% below the 52-week high.
Oct 5, 2026 — NTRB rises 2.6% to $7.47
- Closed at $7.47, +2.61% vs the prior close of $7.28. Day range $7.23–$7.65, opened at $7.24.
- Volume was 19.40K shares, 0.3x its 50-day average of 74.54K — lighter than usual.
- Price is +44.3% vs its 50-day average ($5.18) and +77.6% vs its 200-day average ($4.21).
- 52-week range $2.80–$9.19; today's close sits at 73% of that range, 18.7% below the 52-week high.
Oct 2, 2026 — NTRB dips 1.1% to $7.28, 3 down days in a row
- Closed at $7.28, -1.09% vs the prior close of $7.36. Day range $7.25–$7.86, opened at $7.46.
- Volume was 47.00K shares, 0.6x its 50-day average of 73.88K.
- Price is +43.2% vs its 50-day average ($5.09) and +73.7% vs its 200-day average ($4.19).
- 52-week range $2.80–$9.19; today's close sits at 70% of that range, 20.7% below the 52-week high.
- That makes 3 straight losses.
NTRB latest news & SEC filings
Every SEC filing by or about NTRB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 25-NSE — Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 15, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 31, 2026:
- Revenue: $437.51K (prior year $622.45K) (-29.7% vs Jul 31, 2025)
- Net income: -$880.56K (prior year -$2.00M) (loss narrowed vs Jul 31, 2025)
- Diluted EPS: -$0.07 (prior year -$2.12) (loss narrowed vs Jul 31, 2025)
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Things to know before you trade NTRB
- Last results release: May 15, 2018 (8-K Item 2.02). Previous ones: Aug 18, 2017. Based on that rhythm, the next report is likely around Aug 14, 2018 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.87% (largest 22.3%). That is a volatile stock.
- Liquidity: about 123.14K shares (≈$765.94K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $6.22 vs a range of $2.80–$9.19 (54% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 23, 2026; 10-Q Sep 4, 2026; 8-K Jun 22, 2026.
- Share count: 12.16M shares outstanding (Sep 4, 2026), +1.0% vs a year earlier.
- Listing: Nasdaq · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
NTRB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 6.34 | 6.52 | 6.00 | 6.22 | 27.92K |
| Oct 15, 2026 | 6.30 | 6.80 | 6.25 | 6.27 | 70.20K |
| Oct 14, 2026 | 6.50 | 6.64 | 6.30 | 6.32 | 51.70K |
| Oct 13, 2026 | 5.89 | 6.80 | 5.89 | 6.52 | 69.00K |
| Oct 12, 2026 | 6.57 | 6.57 | 5.85 | 5.85 | 15.60K |
| Oct 9, 2026 | 6.00 | 6.82 | 5.70 | 6.65 | 45.10K |
| Oct 8, 2026 | 6.75 | 6.75 | 6.03 | 6.05 | 35.70K |
| Oct 7, 2026 | 6.58 | 7.10 | 6.58 | 6.76 | 10.20K |
| Oct 6, 2026 | 7.44 | 7.44 | 6.55 | 6.68 | 87.00K |
| Oct 5, 2026 | 7.24 | 7.65 | 7.23 | 7.47 | 19.40K |
| Oct 2, 2026 | 7.46 | 7.86 | 7.25 | 7.28 | 47.00K |
| Oct 1, 2026 | 7.52 | 7.69 | 7.28 | 7.36 | 42.20K |
| Sep 30, 2026 | 8.25 | 8.44 | 7.41 | 7.52 | 145.80K |
| Sep 29, 2026 | 8.31 | 8.57 | 8.03 | 8.25 | 139.50K |
| Sep 28, 2026 | 7.99 | 8.99 | 7.99 | 8.23 | 282.60K |
| Sep 25, 2026 | 9.09 | 9.19 | 7.10 | 8.00 | 408.60K |
| Sep 24, 2026 | 7.35 | 9.00 | 7.35 | 8.99 | 382.00K |
| Sep 23, 2026 | 6.75 | 7.50 | 6.56 | 7.35 | 129.70K |
| Sep 22, 2026 | 7.78 | 7.88 | 6.66 | 6.76 | 319.00K |
| Sep 21, 2026 | 8.21 | 8.55 | 7.30 | 7.77 | 134.60K |
About NutriBand
NutriBand (NTRB) is listed on the Nasdaq and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in ORLANDO, FL. State of incorporation: NV. Fiscal year ends January 31. SEC CIK 1676047.
NTRB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gareth Sheridan | Chief Executive Officer | Nov 25, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gerald Goodman | Chief Financial Officer | Oct 21, 2025 |
| Gareth Sheridan | Chief Executive Officer | Nov 25, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
NTRB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jan 31, 2026 | $2.04M | $-8.23M | -2.58 | $-5.13M |
| Jan 31, 2025 | $2.14M | $-10.48M | -0.99 | $-4.63M |
| Jan 31, 2024 | $2.09M | $-5.49M | -0.69 | $-3.53M |
| Jan 31, 2023 | $2.08M | $-4.48M | -0.53 | $-2.99M |
| Jan 31, 2022 | $1.42M | $-6.18M | -0.80 | $-2.81M |
Latest balance sheet: total assets $6.29M, total liabilities $964.36K, cash $3.42M (as of Jul 31, 2026).
NTRB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 15, 2018 | 8-K Item 2.02 (results) | — |
| Aug 18, 2017 | 8-K Item 2.02 (results) | — |
Related stocks · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Zimmer Biomet (ZBH)Align Technology (ALGN)Steris (STE)MSA Safety (MSA)Smith & Nephew (SNN)Enovis (ENOV)Establishment Labs (ESTA)Cadre (CDRE)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NTRB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.